The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
Open accessAbstract
The dominant TLR5(R392X) polymorphism abrogates flagellin responses in >7% of humans. We report that TLR5-dependent commensal bacteria drive malignant progression at extramucosal locations by increasing systemic IL-6, which drives mobilization of myeloid-derived suppressor cells (MDSCs). Mechanistically, expanded granulocytic MDSCs cause γδ lymphocytes in TLR5-responsive tumors to secrete galectin-1, dampening antitumor immunity and accelerating malignant progression. In contrast, IL-17 is consistently upregulated in TLR5-unresponsive tumor-bearing mice but only accelerates malignant progression in IL-6-unresponsive tumors. Importantly, depletion of commensal bacteria abrogates TLR5-dependent differences in tumor growth. Contrasting differences in inflammatory cytokines and malignant evolution are recapitulated in TLR5-responsive/unresponsive ovarian and breast cancer patients. Therefore, inflammation, antitumor immunity, and the clinical outcome of cancer patients are influenced by a common TLR5 polymorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the natural immunosurveillance of cancers can be negatively impacted by gut commensals through TLR5- and IL-6-dependent inflammation.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [36]
In the citing paper
“The gut microbiome has been shown to have multiple effects on tumor biology, such as the transformation process, tumor progression, and the response to anticancer therapies including immunotherapy (21-29).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [29]
In the citing paper
“The interaction resulted in IL-6-dependent mobilization of MDSCs and subsequently more γδT cells producing immunosuppressive galectin-1, followed by impaired antitumor response and accelerated malignant progression [60] (Fig. 2).”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [60]
In the citing paper
“The notion was further supported by another study showing bacterial flagellin stimulated pro-tumoral inflammation through TLR5 signaling [60].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint
Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,927
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y., & Weiser, J. N. (2010) · Nature Medicine · doi:10.1038/nm.2087 · Cited by 1,154
Jonkers, J., Meuwissen, R. L. J., van der Gulden, H. M. L., Peterse, H. L., van der Valk, M., & Berns, A. J. M. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,044
Commensal bacteria calibrate the activation threshold of innate antiviral immunity
Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A., Antenus, M., Williams, K. L., Erikson, J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.011 · Cited by 993
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 868
Kryczek, I., Banerjee, M., Cheng, P. J., Vatan, L., Szeliga, W., Wei, S., Huang, E. H., Finlayson, E. V. A., Simeone, D. M., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 852
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653
Self-citation
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 311
Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions
Ma, Z., Qu, M., & Wang, X. (2022) · Polish Journal of Microbiology · doi:10.33073/pjm-2022-019 · Cited by 54
Erdman, S. E., & Poutahidis, T. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.05.007 · Cited by 55
Blidner, A. G., Bach, C. A., García, P. A., Merlo, J. P., Cagnoni, A. J., Bannoud, N., Cocco, M. N. M., Pérez‐Sáez, J. M., Pinto, N. A., Torres, N. I., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.027 · Cited by 53
Self-citationPotential links between the microbiota and T cell immunity determine the tumor cell fate
Mohseni, A. H., Taghinezhad‐S, S., Casolaro, V., Lv, Z., & Li, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05560-2 · Cited by 54
Tabatabaei, P., Visse, E., Bergström, P., Brännström, T., Siesjö, P., & Bergenheim, A. T. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2271-1 · Cited by 52
Filippou, C., Themistocleous, S., Marangos, G., Panayiotou, Y., Fyrilla, M., Kousparou, C. A., Pana, Z. D., Tsioutis, C., Johnson, E. O., & Yiallouris, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021110 · Cited by 49
Llitjos, J., Auffray, C., Alby‐Laurent, F., Rousseau, C., Merdji, H., Bonilla, N., Toubiana, J., Belaïdouni, N., Mira, J. P., Lucas, B., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4744 · Cited by 51
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Rosean, C. B., Feng, T.-Y., Azar, F. N., & Rutkowski, M. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.005 · Cited by 52
Self-citationCommensal bacteria modulate the tumor microenvironment
Poutahidis, T., & Erdman, S. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.12.028 · Cited by 48
Khan, A. A., Khan, Z., & Warnakulasuriya, S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw053 · Cited by 50
Clark, N. M., Martinez, L. M., Murdock, S. J., DeLigio, J. T., Olex, A. L., Effi, C., Dozmorov, M. G., & Bos, P. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108482 · Cited by 50
Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application
Li, D., Zhu, L., Wang, Y., Zhou, X., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115120 · Cited by 47
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Guan, D., Wang, Z., Li, X., Dong, S., Huang, J., & Zhou, W. (2023) · MedComm · doi:10.1002/mco2.417 · Cited by 47
Dajon, M., Iribarren, K., Petitprez, F., Marmier, S., Mansuet‐Lupo, A., Gillard, M., Ouakrim, H., Victor, N., Bartolo, V. D., Joubert, P.-E., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1505174 · Cited by 49
Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond
Khoshbin, A. P., Eskian, M., Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0531-9 · Cited by 46
The Relationship Between Microbial Community and Breast Cancer
Song, X., Wei, C., & Li, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.849022 · Cited by 45
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Papakonstantinou, A., Nuciforo, P. G., Borrell, M., Zamora, E., Pimentel, I., Saura, C., & Oliveira, M. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102470 · Cited by 45
Le, F., Yang, L., Han, Y., Zhong, Y., Zhan, F., Feng, Y., Hu, H., Chen, T., & Tan, B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704001 · Cited by 46
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He, Y., Huang, J., Li, Q., Xia, W., Zhang, C., Liu, Z., Xiao, J., Yi, Z., Deng, H., Xiao, Z., et al. (2022) · Cancers · doi:10.3390/cancers14215317 · Cited by 47
Role of the gut microbiota in tumorigenesis and treatment
Liu, Q., Yang, Y., Pan, M., Yang, F., Yu, Y., & Qian, Z. (2024) · Theranostics · doi:10.7150/thno.91700 · Cited by 46
Immunotherapy for Breast Cancer: Current and Future Strategies
Williams, A. D., Payne, K. K., Posey, A. D., Hill, C., Conejo-Garcia, J. R., June, C. H., & Tchou, J. C. (2017) · Current Surgery Reports · doi:10.1007/s40137-017-0194-1 · Cited by 43
Self-citationGut γδ T cells as guardians, disruptors, and instigators of cancer
Suzuki, T., Hayman, L., Kilbey, A., Edwards, J., & Coffelt, S. B. (2020) · Immunological Reviews · doi:10.1111/imr.12916 · Cited by 43
Fernandes, Â., Azevedo, C. M., Silva, M. C., Faria, G., Dantas, C. S., Vicente, M. M., & Pinho, S. S. (2022) · Immunology · doi:10.1111/imm.13494 · Cited by 42
The gut microbiota and immune checkpoint inhibitors
Humphries, A., & DAUD, A. I. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1442970 · Cited by 42
Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet
Hockl, P. F., Wolosiuk, A., Pérez‐Sáez, J. M., Bordoni, A., Croci, D. O., Terrones, Y. T., Soler‐Illia, G. J. A. A., & Rabinovich, G. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.005 · Cited by 40
Self-citationYang, Z., Feng, J. C., Li, X., Chen, X., Yao, Y., Li, Y., Tang, Y., Zhang, S., Lu, M. M., Yu, Q., et al. (2019) · Hepatology · doi:10.1002/hep.30924 · Cited by 39
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics
Wang, J., Zhang, J., Wang, J., Hu, X., Ouyang, L., & Wang, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01655 · Cited by 39
The influence of the commensal microbiota on distal tumor-promoting inflammation
Rosean, C. M. B., & Rutkowski, M. R. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.06.002 · Cited by 40
Self-citationYan, L., Liang, J., Yao, C., Wu, P., Zeng, X., Cheng, K., & Yin, H. H. (2015) · ChemMedChem · doi:10.1002/cmdc.201500471 · Cited by 39
The Role of Toll-Like Receptors in Oncotherapy
Liu, C., Han, C., & Liu, J. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504019x15498329881440 · Cited by 38
Glycan–Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them
Kremsreiter, S. M., Kroell, A.-S. H., Weinberger, K., & Boehm, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910577 · Cited by 42
Shah, D., Comba, A., Faisal, S. M., Kadiyala, P., Baker, G. J., Alghamri, M. S., Doherty, R., Zamler, D. B., Núñez, G., Castro, M. G., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1939601 · Cited by 37
Davicino, R. C., Méndez‐Huergo, S. P., Eliçabe, R. J., Stupirski, J. C., Autenrieth, I. B., Genaro, M. S. D., & Rabinovich, G. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700579 · Cited by 34
Self-citationLi, C., Donninger, H., Eaton, J. W., & Yaddanapudi, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01525 · Cited by 38
The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
Orlacchio, A., & Mazzone, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312743 · Cited by 34
Hu, J., Ran, S., Huang, Z., Liu, Y., Hu, H., Zhou, Y., Ding, X., Yin, J., & Zhang, Y. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.06.042 · Cited by 33
IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors
Allegrezza, M. J., Rutkowski, M. R., Stephen, T. L., Svoronos, N., Tesone, A. J., Perales‐Puchalt, A., Nguyen, J. M., Sarmin, F., Sheen, M. R., Jeng, E. K., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2808 · Cited by 34
Self-citationDietary Recombinant Phycoerythrin Modulates the Gut Microbiota of H22 Tumor-Bearing Mice
Qi, H., Liu, Y., Qi, X., Liang, H. W., Chen, H., Jiang, P., & Wang, D. (2019) · Marine Drugs · doi:10.3390/md17120665 · Cited by 32
Butyrate as a Potential Modulator in Gynecological Disease Progression
Kim, N., & Yang, C. (2024) · Nutrients · doi:10.3390/nu16234196 · Cited by 33
Microbiome and host crosstalk: A new paradigm to cancer therapy
Singh, A. K., Nayak, N., Rathi, P., Verma, D., Sharma, R., Chaudhary, A., Agarwal, A., Tripathi, Y. B., & Garg, N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.014 · Cited by 32
Roles of Microbiota in Cancer: From Tumor Development to Treatment
Bagheri, Z., Moeinzadeh, L., & Razmkhah, M. (2022) · Journal of Oncology · doi:10.1155/2022/3845104 · Cited by 32
Zhao, Y., Liu, Z., Qin, L., Wang, T., & Bai, O. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.03.010 · Cited by 31
Metabolic influence on the differentiation of suppressive myeloid cells in cancer
Porta, C., Marino, A., Consonni, F. M., Bleve, A., Mola, S., Storto, M., Riboldi, E., & Sica, A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy088 · Cited by 31
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Microbiota as the unifying factor behind the hallmarks of cancer
Benešová, I., Křížová, Ľ., & Kverka, M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05244-6 · Cited by 34
Inflammation and skeletal metastasis
Roca, H., & McCauley, L. K. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.75 · Cited by 29
Park, G. B., & Kim, D. (2017) · Oncology Reports · doi:10.3892/or.2017.5941 · Cited by 30
Common TLR5 Mutations Control Cancer Progression
Pfirschke, C., Garris, C., & Pittet, M. J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.008 · Cited by 29
Sun, X., Cai, Y., Fleming, C., Tong, Z., Wang, Z., Ding, C., Qu, M., Zhang, H., Suo, J., & Yan, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1313369 · Cited by 29
The β3‐integrin endothelial adhesome regulates microtubule‐dependent cell migration
Atkinson, S. J., Gontarczyk, A. M., Alghamdi, A. A. A., Ellison, T. S., Johnson, R. T., Fowler, W. J., Kirkup, B. M., Silva, B. C., Harry, B. E., Schneider, J. G., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744578 · Cited by 30
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Videla-Richardson, G. A., Morris-Hanon, O., Torres, N. I., Esquivel, M. I., Vera, M. B., Ripari, L. B., Croci, D. O., Sevlever, G. E., & Rabinovich, G. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010316 · Cited by 29
Self-citationAttar, M. K. A., Anwar, M. A., Eskian, M., Keshavarz‐Fathi, M., Choi, S., & Rezaei, N. (2017) · Medicinal Research Reviews · doi:10.1002/med.21480 · Cited by 28
Pelka, M. A., Trautmann, S., Petschelt, A., & Lohbauer, U. (2010) · PubMed · Cited by 29
Gamma delta T cells and their immunotherapeutic potential in cancer
Cieslak, S. G., & Shahbazi, R. (2025) · Biomarker Research · doi:10.1186/s40364-025-00762-6 · Cited by 33
Alamino, V. A., Montesinos, M. D. M., Soler, M. F., Giusiano, L., Gigena, N., Fozzatti, L., Maller, S. M., Méndez‐Huergo, S. P., Rabinovich, G. A., & Pellizas, C. G. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000025 · Cited by 28
Self-citationGalectin functions in cancer-associated inflammation and thrombosis
Kruk, L., Braun, A., Cosset, E. C., Gudermann, T. W., & Mammadova‐Bach, E. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1052959 · Cited by 32
Prohibitin – At the crossroads of obesity-linked diabetes and cancer
Mishra, S., & Nyomba, B. L. G. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217703976 · Cited by 30
Goc, J., Hepworth, M. R., & Sonnenberg, G. F. (2015) · International Immunology · doi:10.1093/intimm/dxv056 · Cited by 27
Xu, T., Fu, D., Ren, Y., Dai, Y., Lin, J., Tang, L., & Ji, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16050 · Cited by 27
Galectins in the Tumor Microenvironment: Focus on Galectin-1
Martínez‐Bosch, N., & Navarro, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_2 · Cited by 27
Masuda, J., Umemura, C., Yokozawa, M., Yamauchi, K., Seko, T., Yamashita, M., & Yamashita, Y. (2018) · Nutrients · doi:10.3390/nu10101380 · Cited by 29
Galectin-1 is essential for efficient liver regeneration following hepatectomy
Potikha, T., Ella, E., Cerliani, J. P., Mizrahi, L., Pappo, O., Rabinovich, G. A., Galun, E., & Goldenberg, D. (2016) · Oncotarget · doi:10.18632/oncotarget.9194 · Cited by 26
Self-citationNucleoside Diphosphate Kinase-3 ( NME3 ) Enhances TLR5-Induced NF κ B Activation
Flentie, K., González, C., Kocher, B. A., Wang, Y., Hongtu Zhu, B., Marasa, J. C., & Piwnica-Worms, D. R. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0603 · Cited by 27
Tissue-specific control of galectin-1-driven circuits during inflammatory responses
Cutine, A. M., Bach, C. A., Veigas, F., Merlo, J. P., Laporte, L., Cocco, M. N. M., Massaro, M., Sarbia, N., Perrotta, R. M., Mahmoud, Y. D., et al. (2021) · Glycobiology · doi:10.1093/glycob/cwab007 · Cited by 28
Self-citationAnde, S. R., Nguyen, K. H., Padilla‐Meier, G. P., Nyomba, B. L. G., & Mishra, S. (2016) · Oncogene · doi:10.1038/onc.2015.501 · Cited by 29
Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility
Shuang, C., Yuan, W., Fu, Z., Yike, H., Yang, J., Jing, X., Xinghan, L., Yue, L., & Li, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20242 · Cited by 25
Guo, X., Liu, Y., Kim, J. L., Kim, E. Y., Kim, E. Q., Jansen, A., Li, K., Chan, M., Keenan, B. T., Conejo-Garcia, J., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212930 · Cited by 23
Self-citationNovák, J., Takács, T., Tilajka, Á., László, L., Oravecz, O., Farkas, E., Than, N. G., Buday, L., Balogh, A., & Vas, V. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01047-8 · Cited by 27
Hullar, M. A. J., Lampe, J. W., Torok‐Storb, B., & Harkey, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197686 · Cited by 24
The intratumoral microbiota: a new horizon in cancer immunology
Liu, W., Li, Y., Wu, P., Guo, X., Xu, Y., Jin, L., & Zhao, D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1409464 · Cited by 22
Chi, X., Liu, Z., Wei, W., Hu, X., Wang, Y., Wang, H., & Xu, B. (2021) · Food & Function · doi:10.1039/d1fo01070k · Cited by 23
Evolutionary concepts in the functional biotics arena: a mini-review
Nataraj, B. H., Shivanna, S. K., Rao, P. M., Nagpal, R., & Behare, P. V. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-020-00818-3 · Cited by 22
Niccolai, E., Boem, F., Emmi, G., & Amedei, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.03.001 · Cited by 23
Interactions between the tumor microbiota and breast cancer
Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 22
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
Laderach, D. J., & Compagno, D. (2021) · Cancers · doi:10.3390/cancers13184529 · Cited by 22
Masuda, J., Shigehiro, T., Matsumoto, T., Satoh, A., Mizutani, A., Umemura, C., Saito, S., Kijihira, M., Takayama, E., Seno, A., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041261 · Cited by 21
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
Haderski, G. J., Kandar, B. M., Brackett, C. M., Toshkov, I. A., Johnson, C. P., Paszkiewicz, G., Natarajan, V., Gleiberman, A. S., Gudkov, A. V., & Burdelya, L. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227940 · Cited by 21
Zhang, Y., Tang, N., Zhou, H., & Zhu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116218 · Cited by 21
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
Giurini, E. F., Madonna, M. B., Zloza, A., & Gupta, K. H. (2022) · Cancers · doi:10.3390/cancers14122923 · Cited by 20
Trifanescu, O. G., Trifanescu, R. A., Mitrica, R. I., Bran, D. M., Serbanescu, L. G., Valcauan, L., Marinescu, Ș. A., Gales, L. N., Tănase, B. C., & Anghel, R. M. (2023) · Diagnostics · doi:10.3390/diagnostics13050877 · Cited by 25
Microbiote intestinal et réponses aux thérapies anti-tumorales
Vétizou, M., Daillère, R., & Zitvogel, L. (2016) · médecine/sciences · doi:10.1051/medsci/20163211013 · Cited by 21
Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance
Mendoza‐Reinoso, V., Baek, D. Y., Kurutz, A., Rubin, J. R., Koh, A. J., McCauley, L. K., & Roca, H. (2020) · Cells · doi:10.3390/cells9020429 · Cited by 20
Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
Pinto, N. A., Abba, M. C., Laporte, L., Sáez, J. M. P., Blidner, A. G., Torres, N. I., Morales, R. M., Gatto, S. G., Bach, C. A., Veigas, F., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-022-01108-7 · Cited by 19
Self-citationWang, J., Pu, J., Zhang, Z., Feng, Z., Han, J., Su, X., & Shi, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16682 · Cited by 19
Terawaki, K., Kashiwase, Y., Uzu, M., Nonaka, M., Sawada, Y., Miyano, K., Higami, Y., Yanagihara, K., Yamamoto, M., & Uezono, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.26190 · Cited by 19
Potikha, T., Pappo, O., Mizrahi, L., Olam, D., Maller, S. M., Rabinovich, G. A., Galun, E., & Goldenberg, D. (2019) · The FASEB Journal · doi:10.1096/fj.201900017r · Cited by 18
Self-citationUncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review
Halsey, T. M., Ologun, G. O., Wargo, J. A., & Jenq, R. R. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.05.002 · Cited by 19
Immune mediated support of metastasis: Implication for bone invasion
Xin, Z., Qin, L., Tang, Y., Guo, S., Li, F., Yuan, F., Li, G., Yao, Y., Zheng, B., Zhang, B., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12584 · Cited by 23
Wang, X., Zhang, Y., & Liu, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-11041-x · Cited by 18
The microbiome: a link between obesity and breast cancer risk
Gaber, M. K., Arnone, A. A., Vidi, P., & Cook, K. L. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1394719 · Cited by 21
Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy
Payne, K. K. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1213278 · Cited by 18
Bouferraa, Y., Chedid, A., Amhaz, G., Lakkiss, A. E., Mukherji, D., Temraz, S. N., & Shamseddine, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158036 · Cited by 18
Impact of the ileal microbiota on colon cancer
Roberti, M. P., Rauber, C., Kroemer, G., & Zitvogel, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.016 · Cited by 18
Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis
Ibragimova, S., Ramachandran, R., Ali, F. R., Lipovich, L., & Ho, S. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725821 · Cited by 18
Choi, S.-Y., & Choi, J. (2024) · Medicina · doi:10.3390/medicina60030516 · Cited by 17
Mattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 17
Zhang, Q., Wang, D., Zhuo, G., Wang, S., Yuan, Y., Wang, L., Ji, L., Wan, Y., Liu, G., & Pan, Y. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.98260 · Cited by 16
Prospects for Immunotherapy of Acute Myeloid Leukemia Using γδ T Cells
Halim, L., Parente‐Pereira, A. C., & Maher, J. F. (2017) · Immunotherapy · doi:10.2217/imt-2016-0139 · Cited by 16
Masuda, J., Takayama, E., Strober, W., Satoh, A., Morimoto, Y., Honjo, Y., Ichinohe, T., Tokuno, S., Ishizuka, T., Nakata, T., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5646 · Cited by 16
Extension and refinement of the recognition motif for Toll-like receptor 5 activation by flagellin
Ivičak‐Kocjan, K., Forstnerič, V., Panter, G., Jerala, R., & Benčina, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3vma0118-035r · Cited by 15
Metadata
- Authors
- Rutkowski, M. R., Stephen, T. L., Svoronos, N., Allegrezza, M. J., Tesone, A. J., Perales-Puchalt, A., Brencicova, E., Escovar-Fadul, X., Nguyen, J. M., Cadungog, M. G., Zhang, R., Salatino, M., Tchou, J., Rabinovich, G. A., & Conejo-Garcia, J. R.
- Affiliations
- The Wistar Institute (US)
- Christiana Care Health System (US)
- University of Pennsylvania (US)
- Abramson Cancer Center (US)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- Conejo-Garcia, Jose R.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 27
- Issue
- 1
- Pages
- 27-40
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4293269
- OpenAlex
- W2164918734
- Cited by
- 311
- References
- 28
- Citations by year
- 2026: 13 · 2025: 28 · 2024: 24 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 35 · 2016: 35 · 2015: 16
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Conicet (submittedVersion, cc-by-nc-sa)
- Funders
- National Cancer Institute (CA010815, R01CA157664, U54CA151662, R01CA178687, R01CA163377, R01CA124515, T32CA009171, P30CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- TLR5, flagellin, commensal bacteria, tumor-promoting inflammation, myeloid-derived suppressor cells, granulocytic MDSCs, γδ T cells, galectin-1, interleukin-6, IL-17, antitumor immunity, malignant progression, ovarian cancer, breast cancer, microbiome
- MeSH terms
- Animals, Cells, Cultured, Humans, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Neoplasm Transplantation, Neoplasms, Signal Transduction, Interleukin-6, Gene Expression Regulation, Neoplastic, Interleukin-17, Polymorphism, Single Nucleotide, Galectin 1, Cell Line, Tumor, Toll-Like Receptor 5, Mice, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
